Monday 29th April 2024

Health Tech Spring Conference

Date & Time

April 29 · 2pm - April 30 · 5pm

Venue

Titanic Belfast, 1 Olympic Way Belfast BT3 9EP

About Event

Hosted by the Health Innovation and Research Alliance NI (HIRANI), Health Tech Spring is a two-day conference taking place in Belfast on 29 & 30 April 2024.

With local and global partners, the conference will focus on two strands; digital ecosystems to integrate diagnostics and therapeutics; and community people-centred design to accelerate innovation and adoption of health technology.

Following on from a sold-out summit last year, HIRANI have expanded the event into a two-day conference which will include a “Life Sciences, Life Support” event for businesses who provide support services to the life science industry. With Innovation zones and pitching events, global keynotes and local thought leaders, Health Tech Spring promises to be an iconic conference hosted in the Titanic Building.

Day one Monday 29th April 2024 FREE EVENT
1.30pm to 5.30pm followed by a HIRANI pulse networking event.

Taking place in The Andrews Gallery at the Titanic Building in Belfast,  our Life Sciences, Life Support event will showcase everything from funding to design, regulation to promotion – all  you need to know to start or expand your innovation journey.

With 25 exhibitors, masterclasses, bootcamps, and networking events – this is a day not to be missed for anyone involved with, or interested in, NI Health and Life Science. From communications to legal, finance, investment and regulatory workshops,  the event will provide opportunities to innovators to network and connect with the support they need to progress their idea from concept to market.

Day two Tuesday 30th April 2024 
From 9.30am to 5.30pm

Following on from a sold-out summit last year, HIRANI have expanded the event to include Innovation zones and pitching events, global keynotes and local thought leaders.

Over 50 speakers from global and indigenous industry, academia and health along with 500 delegates will share case-studies and take part in multi-disciplinary panel sessions to explore contemporary issues.

PLEASE NOTE: With the Health Tech Spring Full Conference Ticket, you are permitted to attend the Life Sciences, Life Support free event and do not require to purchase an additional ticket.

Conor Murphy

Conor Murphy MLA was appointed Economy Minister on 3 February 2024.

Having first been elected to the Assembly in 1998, Mr Murphy served as Finance Minister between 2020 and 2022 and Minister for Regional Development between 2007 and 2011. He has also been a member of the Enterprise, Trade and Investment Committee and the Public Accounts Committee.

Mr Murphy was MP for Newry and Armagh between 2005 and 2015.

Dr Victoria Manax

Medical Oncologist

Victoria Manax M.D., is a medical oncologist with over 20 years of experience in solid tumor cancer states. She specializes in global drug development, medical affairs, and patient advocacy. Dr. Manax has been involved in the development, approval, and launch of multiple billion-dollar drugs including the standard of care for pancreatic cancer, Abraxane. Most well-known for innovative clinical trial designs, Dr. Manax has managed many $100M global clinical trial programs and is a well-known panelist amongst regulatory agencies around the world.  She currently holds several clinical advisory positions, patents, and chair positions for multiple data, safety, and monitoring boards. Dr. Manax is on the board for TrovaNOW, Data Safety Monitoring Chair (DSMC) of REMAP-CAP for COVID-19, and DSMC co-chair for ATTACC (Antithrombotic Therapy to Ameliorate Complications of COVID-19). She most recently served as the Chief Medical Officer of the Pancreatic Cancer Action Network and was the GI Disease Lead at Celgene.

Victoria is also part of the US Life Sciences Advisory Board to Northern Ireland https://hira-ni.com/usa-life-and-health-advisory-board/

Dr Hakim Yadi

Chair of the Board

Hakim is a Co-Founder and Chief Executive of Closed Loop Medicine. Closed Loop Medicine (CLM) is a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. The company combines proven drugs with digital therapeutics and, where relevant, devices and diagnostics, through a single prescription enabling the digitisation and data capture of an entire care continuum.

He joined CLM from the Northern Health Science Alliance Ltd, the pan-Northern health partnership which brought together for the first time 20 research-based NHS hospitals, the North’s Academic Health Science Networks and Universities to collaborate on improving health outcomes across the North.

He holds a PhD from the University of Cambridge and in 2017 he was awarded an OBE for services to Healthcare Technology and the Economy. Hakim is also Chair of the HIRANI Board of Directors.

Rebecca Walsh

Rebecca is an award-winning service designer, engineer and digital health expert. A Chartered Mechanical Engineer (IMechE), Rebecca holds an MEng (Hons) Aerospace Engineering from Queen’s University Belfast and brings over ten years of experience in user-centred design and service innovation to her role as Service Design Director at Big Motive.

Rebecca is responsible for the delivery of high-quality experience health design projects for a range of Big Motive’s clients, spanning private health technology startups to large public sector health systems. As a teacher and advisor, Rebecca is member of Matrix, Northern Ireland’s Science Industry Panel and delivers an interactive design-led module for the MBA programme at Queen’s University.

Professor William Gallagher

Professor of Cancer Biology
University College Dublin Co-Lead
All-Island Cancer Research Institute (AICRI) Scientific Director
St. Vincent’s-UCD Cancer Centre

Professor William Gallagher is Full Professor of Cancer Biology at University College Dublin (UCD) and Deputy Director of Precision Oncology Ireland, a large-scale Science Foundation Ireland (SFI) Strategic Partnership Programme involving 5 academic institutions, 6 cancer charities and 7 companies (www.precisiononcology.ie). He is also Scientific Director of the recently established St. Vincent’s-UCD Cancer Centre (www.stvincentsucdcancercentre.ie/).

Currently, Prof. Gallagher is a primary driving force behind the All-Island Cancer Research Institute (AICRI), which is creating an overarching framework for cancer research across the entire island of Ireland (www.aicri.org). AICRI-linked programmes were recently awarded over 12 million euro under the recent HEA North-South Research Programme, including an all-island Doctoral and Post-Doctoral Training Programme in Precision Cancer Medicine (AICRIstart) which Prof. Gallagher co-leads.

From 2016-2021, Professor Gallagher was Director of the UCD Conway Institute of Biomolecular and Biomedical Research, one of Ireland’s largest biomedical research facilities. From 2013-2019, he was the Director of BREAST-PREDICT, which was the first Irish Cancer Society Collaborative Cancer Research Centre (CCRC) to be funded (www.breastpredict.com). This country-wide CCRC, which was supported to the level of 7.5 million euro and involved 6 academic institutions, as well as Cancer Trials Ireland, focused on developing more personalised treatment approaches for breast cancer.

Prof. Gallagher has received a number of awards for his research and innovation achievements in the oncology arena, including the inaugural Irish Association for Cancer Research Medal in 2017, the SFI Entrepreneurship Award in 2019 and the SFI Researcher of the Year Award in 2021. Prof. Gallagher has co-founded two molecular diagnostics companies, OncoMark Ltd. and OncoAssure Ltd., the former being acquired in March 2021 by the US company Danaher (Cepheid division).

Richard Kennedy

Richard Kennedy is Professor of Medical Oncology at Queen’s University of Belfast and Global VP and Medical Director at Almac. He graduated in medicine from Queen’s University Belfast in 1995. As a post-graduate he trained as a medical oncologist and received a PhD in Molecular Biology in 2004. From 2004-2007 he worked as an Instructor in Oncology at Harvard Medical School, USA, where he identified novel biomarkers and drug targets for cancer treatment.

This work was published in several high impact journals and the associated patent was in-licensed by a Boston-based start-up company in 2007. In August 2007 he joined Almac Diagnostic Services as a College of American Pathologists approved molecular lab director and has been responsible for the development and delivery of precision medicine biomarkers in over 300 clinical studies on behalf of multiple large pharmaceutical companies.

In 2011 he also established a research group In Queen’s University Belfast focussed on various aspects of precision medicine. He continues to publish regularly in this field. He currently sits on the MATRIX NI Government science advisory panel and the Royal College of Physicians Faculty of Pharmaceutical Medicine Oncology Advisory group. He is a past member of the MRC Stratified Medicine Panel and the CR-UK new agents committee.

Kerry Curran

Director, GB & Eu Trade Division, Department for the Economy

Kerry leads the Departments work to ensure Northern Ireland business opportunities are maximised in both the UK and Europe. She also has lead responsibility for the development of the Life and Health Sciences focus in the 10X Economy Strategy.

Kerry previously led the InterTradeIreland strategy, policy, research, and partnerships functions. She has more than twenty years’ experience of working in strategic policy research roles and has held similar roles at Queen’s University Belfast, The Environment Agency (GB) and Renewable UK.  She has a degree in Environmental Science, a Masters in Economics in Policy Analysis and a Masters in Business Administration and more than 5 years of Charity Board experience.

Professor Tony Young

Associate Medical Director

Tony is a practicing frontline NHS surgeon, Associate Medical Director at the Mid and South Essex University Hospitals Group, Director of Medical Innovation at Anglia Ruskin University, and has founded 4 Med-Tech start-ups. He has also co-founded the £500 million Anglia Ruskin MedTech Campus.

In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation. In this role he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS, promotes economic growth through innovation and helps make the NHS the go to place on the planet for medical innovation. In 2015 he founded the NHS Clinical Entrepreneur programme. This has become the world’s largest entrepreneurial workforce development programme for clinicians and under the NHS Long Term Plan is set for a major expansion to include entrepreneurs.

In the 2019 New Year’s Honours list Tony was awarded the OBE for services to clinical leadership.

Mahendra Patel

Professor Mahendra G Patel OBE PhD FHEA Alumni FNICE FIPA (India) Hon DHealth FIIOPM FRPharmS

Mahendra is a leading pharmacist and trailblazer in the world of pharmacy. He is a multi-award winner and the first to gain a Fellowship from NICE. He is a founding member and Director of the Centre for Research Equity University of Oxford.

Mahendra is a national lead at the University of Oxford in the world’s largest recruiting clinical trials for Covid-19. His presentation will be about improving inclusive research through two large-scale clinical trials in primary care, which has been showcased on international platforms, including the United Nations and the World Health Organisation.

In 2022 he was made Officer of the British Empire (OBE) for contributions to pharmacy.

Rory Campbell

Rory is a Partner in Lewis Silkin’s Technology & Communications division on Belfast. For over 25 years he has advised clients on technology investments, acquisitions, and deals. Rory’s experience ranges from advising start-ups on the nimble art of protecting and selling their creations at the same time, to advising government departments and public sector bodies on how to ensure value for money and fulfilment of requirements in multi-million-pound IT procurement projects. Rory is passionate about being at forefront of the continual development of best practice tech law as it races to catch up with technological change. He regularly writes and lectures on technology issues, including IT licensing structures, open-source software and data privacy by design in tech products.

Joan Condell

Professor Joan Condell leads the Human Centred Computing team in Ulster University (Northern Ireland) focusing on data analytics, AI and (wearable/ambient) IoT sensors for a range of applied sectors.  She manages a team of PhD researchers and Research Associates/Fellows across multiple national, EU and commercial projects (has led over 100 projects in her career).  Professor Condell has published over 250 papers and actively secured grants from external sources with a total project value over £56M. 

Professor Condell has considerable commercial experience; she is CEO of a spinout company ActionSense Ltd and exited a previous spinout company (HidInImage Ltd).  She has numerous patents filed in UK and US; and has completed trials with key industrial players with a range of technologies.  Joan has won Innovation and Enterprise awards for this commercialisation work for creativity and bio-entrepreneurship.  I plan to present the latest prize our team has won, with Dr Frances Duffy, the Longitude Prize for Dementia and ongoing work in NI with NHSCT and eClear.

Disrupting into the next chapter

Health Tech Spring 2024 provides a stage for thought leaders and influential speakers in healthcare.

Learn how we helped 100 top brands gain success